Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy
(1) Purpose: Malignant pleural mesothelioma (MPM) is a rare cancer with an aggressive course. For patients who are medically inoperable or surgically unresectable, multi-agent systemic chemotherapy remains an accepted standard-of-care. The purpose of this meta-analysis is to provide baseline summati...
Main Authors: | Rupesh Kotecha, Raees Tonse, Muni Rubens, Haley Appel, Federico Albrecht, Paul Kaywin, Evan W. Alley, Martin C. Tom, Minesh P. Mehta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2186 |
Similar Items
-
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01) -
The relationship between treatment cost and prognosis of malignant pleural mesothelioma in Turkey
by: A K Guntulu, et al.
Published: (2019-01-01) -
Secondary Malignant Peritoneal Mesothelioma of the Greater Omentum after Therapy for Primary Pleural Mesothelioma
by: Andreas Gutzeit, et al.
Published: (2013-04-01) -
Malignant pleural mesothelioma in a child
by: Jed Brendan Scharf, et al.
Published: (2015-10-01) -
Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas
by: Mona MLIKA, et al.
Published: (2021-01-01)